|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2006-11-19
|
|
pubmed:abstractText |
The antiproteinuric effect of angiotensin-converting enzyme (ACE) inhibitors appears to vary depending on the ACE insertion (I)/deletion (D) genotype in non-diabetic nephropathy. This interaction may be overcome by using an angiotensin II receptor blocker. We evaluated the short-term antiproteinuric effect of losartan according to the ACE I/D genotype in patients with non-diabetic proteinuric renal diseases.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1420-4096
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
216-24
|
|
pubmed:meshHeading |
pubmed-meshheading:16960460-Adult,
pubmed-meshheading:16960460-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:16960460-Blood Pressure,
pubmed-meshheading:16960460-Diuretics,
pubmed-meshheading:16960460-Drug Therapy, Combination,
pubmed-meshheading:16960460-Female,
pubmed-meshheading:16960460-Gene Deletion,
pubmed-meshheading:16960460-Genotype,
pubmed-meshheading:16960460-Humans,
pubmed-meshheading:16960460-Losartan,
pubmed-meshheading:16960460-Male,
pubmed-meshheading:16960460-Middle Aged,
pubmed-meshheading:16960460-Peptidyl-Dipeptidase A,
pubmed-meshheading:16960460-Polymorphism, Genetic,
pubmed-meshheading:16960460-Prevalence,
pubmed-meshheading:16960460-Proteinuria,
pubmed-meshheading:16960460-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.
|
|
pubmed:affiliation |
Department of Internal Medicine, College of Medicine, Institute of Kidney Disease, Yonsei University, Seoul, Korea.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
